![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
September 30, 2021
The ethical imperative is that we must not treat the patient as a mere subject but as a participant partner, who therefore has rights to information about the trial to which they contributed
July 7, 2021
ECOG-ACRIN has established a Task Force on Advancement for Women under the leadership of Barbara Burtness, MD of Yale University
May 28, 2021
In an annual evaluation, 22 member networks and programs met rigorous standards established by ECOG-ACRIN to indicate exemplary cancer research
April 27, 2021
Most of us are virtual meeting pros by now—and though many miss the connection and energy of in-person events, there is something to be said for attending sessions in sweatpants, a favorite coffee mug in hand
January 25, 2021
Dr. Sparano discusses the scientific and statistical collaboration behind a new tool, RSClin™, which integrates clinical–pathological and genomic risk information to guide adjuvant chemotherapy in node-negative breast cancer
October 19, 2020
The Fall 2020 Group Meeting will look different this year – a fact that should not be too surprising, given that it will take place entirely online
September 14, 2020
Up to eight young investigators will present their work at the annual Young Investigator Symposium, taking place during the Virtual Fall 2020 Group Meeting
July 29, 2020
A special webcast in June focused on moving to an explicit anti-racist ECOG-ACRIN agenda
June 10, 2020
The new virtual meeting format, developed out of necessity, sparked interesting conversations
May 29, 2020
February 28, 2020
Mike Thompson writes that educating and engaging the public--both via social media and in person--is necessary to sustain a national clinical trials infrastructure and continue advancing cancer research
January 14, 2020
